The costs of at least 350 drugs in the U.S. are expected to rise in 2026, according to a new analysis, despite many of the ...
As enhanced subsidies expire, many Americans covered under the Affordable Care Act are having trouble paying for insurance.
ASCO GU 2025 had groundbreaking advancements in genitourinary cancer treatments, focusing on prostate cancer, renal cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback